CPT code 82010 represents a quantitative laboratory assay for ketone bodies in serum or plasma, delivering a numeric result used in diagnosis and monitoring of metabolic states such as diabetic ketoacidosis and other metabolic disorders. As a fully technical laboratory procedure, the code documents the analytic measurement that informs clinical decision-making and inpatient/outpatient care.

Key payers covered in this national overview include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise outline of the clinical context for quantitative ketone testing, typical sites of service, and the common modifier landscape that accompanies laboratory billing for this service. The publication also summarizes typical payer coverage patterns and coding considerations relevant to laboratories and clinical providers.

This piece provides operationally relevant benchmarks and policy context: how the code is used in practice, where it commonly appears on service lines, and what clinical situations typically generate orders for quantitative ketone measurement. Data not available in the input will be identified as such in relevant sections.